3 clinical trials registered. Interventions under study include drug therapy, other interventions, and gene therapy. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
124 publications have been identified in PubMed for acute myeloblastic leukemia with maturation. Kisho has analyzed 90 by research type. Research spans Review / Meta-Analysis (61%), Basic Science / Preclinical (16%), and Diagnostic / Biomarker (8%).
Iqbal U (2026). [PMID: 41474933](https://pubmed.ncbi.nlm.nih.gov/41474933/). *Expert Opin Investig Drugs*. [Review / Meta-Analysis]
Nassani BM (2026). [PMID: 41559819](https://pubmed.ncbi.nlm.nih.gov/41559819/). *J Med Case Rep*. [Case Report / Case Series]
Huls G (2025). [PMID: 39719041](https://pubmed.ncbi.nlm.nih.gov/39719041/). *Blood*. [Review / Meta-Analysis]
Kendrick TS (2025). [PMID: 39774131](https://pubmed.ncbi.nlm.nih.gov/39774131/). *Ann Lab Med*. [Review / Meta-Analysis]
Senapati J (2025). [PMID: 40105906](https://pubmed.ncbi.nlm.nih.gov/40105906/). *Cancer*. [Review / Meta-Analysis]
Boussi L (2025). [PMID: 40615295](https://pubmed.ncbi.nlm.nih.gov/40615295/). *Trends Cancer*. [Review / Meta-Analysis]
Krayem B (2025). [PMID: 40518351](https://pubmed.ncbi.nlm.nih.gov/40518351/). *Blood Rev*. [Review / Meta-Analysis]
Iyer P (2025). [PMID: 39889807](https://pubmed.ncbi.nlm.nih.gov/39889807/). *Pediatr Hematol Oncol*. [Review / Meta-Analysis]
Umeda M (2025). [PMID: 39781610](https://pubmed.ncbi.nlm.nih.gov/39781610/). *Haematologica*. [Review / Meta-Analysis]
Altarawneh M (2025). [PMID: 40585647](https://pubmed.ncbi.nlm.nih.gov/40585647/). *Cureus*. [Case Report / Case Series]
